Literature DB >> 15485929

Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes.

Sharmistha Pal1, Sheethal N Vishwanath, Hediye Erdjument-Bromage, Paul Tempst, Saïd Sif.   

Abstract

Protein arginine methyltransferases (PRMTs) have been implicated in transcriptional activation and repression, but their role in controlling cell growth and proliferation remains obscure. We have recently shown that PRMT5 can interact with flag-tagged BRG1- and hBRM-based hSWI/SNF chromatin remodelers and that both complexes can specifically methylate histones H3 and H4. Here we report that PRMT5 can be found in association with endogenous hSWI/SNF complexes, which can methylate H3 and H4 N-terminal tails, and show that H3 arginine 8 and H4 arginine 3 are preferred sites of methylation by recombinant and hSWI/SNF-associated PRMT5. To elucidate the role played by PRMT5 in gene regulation, we have established a PRMT5 antisense cell line and determined by microarray analysis that more genes are derepressed when PRMT5 levels are reduced. Among the affected genes, we show that suppressor of tumorigenicity 7 (ST7) and nonmetastatic 23 (NM23) are direct targets of PRMT5-containing BRG1 and hBRM complexes. Furthermore, we demonstrate that expression of ST7 and NM23 is reduced in a cell line that overexpresses PRMT5 and that this decrease in expression correlates with H3R8 methylation, H3K9 deacetylation, and increased transformation of NIH 3T3 cells. These findings suggest that the BRG1- and hBRM-associated PRMT5 regulates cell growth and proliferation by controlling expression of genes involved in tumor suppression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15485929      PMCID: PMC522266          DOI: 10.1128/MCB.24.21.9630-9645.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

1.  Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly.

Authors:  J Nakayama ; J C Rice; B D Strahl; C D Allis; S I Grewal
Journal:  Science       Date:  2001-03-15       Impact factor: 47.728

Review 2.  Chromatin remodeling enzymes: who's on first?

Authors:  C J Fry; C L Peterson
Journal:  Curr Biol       Date:  2001-03-06       Impact factor: 10.834

Review 3.  Translating the histone code.

Authors:  T Jenuwein; C D Allis
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

4.  Methylation of SPT5 regulates its interaction with RNA polymerase II and transcriptional elongation properties.

Authors:  Youn Tae Kwak; Jun Guo; Shashi Prajapati; Kyu-Jin Park; Rama M Surabhi; Brady Miller; Peter Gehrig; Richard B Gaynor
Journal:  Mol Cell       Date:  2003-04       Impact factor: 17.970

5.  Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31.

Authors:  J C Zenklusen; C J Conti; E D Green
Journal:  Nat Genet       Date:  2001-04       Impact factor: 38.330

6.  Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes.

Authors:  S Sif; A J Saurin; A N Imbalzano; R E Kingston
Journal:  Genes Dev       Date:  2001-03-01       Impact factor: 11.361

7.  Regulation of transcription by a protein methyltransferase.

Authors:  D Chen; H Ma; H Hong; S S Koh; S M Huang; B T Schurter; D W Aswad; M R Stallcup
Journal:  Science       Date:  1999-06-25       Impact factor: 47.728

8.  Transitions in distinct histone H3 methylation patterns at the heterochromatin domain boundaries.

Authors:  C D Allis; S I Grewal
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

9.  Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor.

Authors:  H Wang; Z Q Huang; L Xia; Q Feng; H Erdjument-Bromage; B D Strahl; S D Briggs; C D Allis; J Wong; P Tempst; Y Zhang
Journal:  Science       Date:  2001-05-31       Impact factor: 47.728

10.  Methylation of histone H3 by coactivator-associated arginine methyltransferase 1.

Authors:  B T Schurter; S S Koh; D Chen; G J Bunick; J M Harp; B L Hanson; A Henschen-Edman; D R Mackay; M R Stallcup; D W Aswad
Journal:  Biochemistry       Date:  2001-05-15       Impact factor: 3.162

View more
  269 in total

1.  Epigenetic mechanisms of Groucho/Grg/TLE mediated transcriptional repression.

Authors:  Sanjeevkumar R Patel; Samina S Bhumbra; Raghavendra S Paknikar; Gregory R Dressler
Journal:  Mol Cell       Date:  2011-12-08       Impact factor: 17.970

2.  Type II arginine methyltransferase PRMT5 regulates gene expression of inhibitors of differentiation/DNA binding Id2 and Id4 during glial cell differentiation.

Authors:  Jinghan Huang; Gillian Vogel; Zhenbao Yu; Guillermina Almazan; Stéphane Richard
Journal:  J Biol Chem       Date:  2011-10-31       Impact factor: 5.157

3.  Structural insights into protein arginine symmetric dimethylation by PRMT5.

Authors:  Litao Sun; Mingzhu Wang; Zongyang Lv; Na Yang; Yingfang Liu; Shilai Bao; Weimin Gong; Rui-Ming Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

Review 4.  Chemical and biochemical approaches in the study of histone methylation and demethylation.

Authors:  Keqin Kathy Li; Cheng Luo; Dongxia Wang; Hualiang Jiang; Y George Zheng
Journal:  Med Res Rev       Date:  2012-07       Impact factor: 12.944

5.  Protein arginine methyltransferase 7 regulates cellular response to DNA damage by methylating promoter histones H2A and H4 of the polymerase δ catalytic subunit gene, POLD1.

Authors:  Vrajesh Karkhanis; Li Wang; Sookil Tae; Yu-Jie Hu; Anthony N Imbalzano; Saïd Sif
Journal:  J Biol Chem       Date:  2012-07-02       Impact factor: 5.157

6.  LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity.

Authors:  Zahid Q Bonday; Guillermo S Cortez; Michael J Grogan; Stephen Antonysamy; Ken Weichert; Wayne P Bocchinfuso; Fengling Li; Steven Kennedy; Binghui Li; Mary M Mader; Cheryl H Arrowsmith; Peter J Brown; Mohammad S Eram; Magdalena M Szewczyk; Dalia Barsyte-Lovejoy; Masoud Vedadi; Ernesto Guccione; Robert M Campbell
Journal:  ACS Med Chem Lett       Date:  2018-04-23       Impact factor: 4.345

Review 7.  Readers of histone methylarginine marks.

Authors:  Sitaram Gayatri; Mark T Bedford
Journal:  Biochim Biophys Acta       Date:  2014-02-28

8.  PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing.

Authors:  Quan Zhao; Gerhard Rank; Yuen T Tan; Haitao Li; Robert L Moritz; Richard J Simpson; Loretta Cerruti; David J Curtis; Dinshaw J Patel; C David Allis; John M Cunningham; Stephen M Jane
Journal:  Nat Struct Mol Biol       Date:  2009-02-22       Impact factor: 15.369

9.  Mutations in the Type II protein arginine methyltransferase AtPRMT5 result in pleiotropic developmental defects in Arabidopsis.

Authors:  Yanxi Pei; Lifang Niu; Falong Lu; Chunyan Liu; Jixian Zhai; Xiangfeng Kong; Xiaofeng Cao
Journal:  Plant Physiol       Date:  2007-06-15       Impact factor: 8.340

10.  Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells.

Authors:  C Elizabeth Caldon; C Marcelo Sergio; Robert L Sutherland; Elizabeth A Musgrove
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.